A Study of RO5285119 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Healthy Volunteer
Interventions
DRUG

RO5285119

single and multiple ascending oral doses

DRUG

placebo

single and multiple oral doses

Trial Locations (2)

35042

Rennes

67064

Strasbourg

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01418963 - A Study of RO5285119 in Healthy Volunteers | Biotech Hunter | Biotech Hunter